Ritanserin in Treatment of Cocaine Dependence - 1

Phase 2

Completed

• Conditions: Cocaine-Related Disorders

• Registration Number: NCT00000187
• Lead Sponsor: University of Pennsylvania

Brief Summary

The purpose of this study is to assess ritanserin as a pharmacotherapy for cocaine dependence.

Detailed Description

Not available

Study Timeline

• Study Start: 1992-07
• Primary Completion: 1994-06
• Study First Submitted: 1999-09-20
• Study First Submitted QC: 1999-09-20
• Study First Posted: 1999-09-21
• Status Verified: 2015-05
• Last Update Submitted: 2015-05-26
• Last Update Posted: 2015-05-28

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Male
• Target Recruitment: 80

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Cocaine use
Cocaine craving

Trial Locations

Locations (1)

University of Pennsylvania; 🇺🇸 Philadelphia, Pennsylvania, United States